Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Stick-On AI patch replace wires for heart monitoring after surgery?

NCT ID NCT07725445

Knowledge-focused Sponsor: HUINNO Co., Ltd Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 24, 2026 · Last updated Jul 31, 2026 · Updated 2 times

Summary

This study tests a small, wearable ECG patch that uses artificial intelligence to monitor heart rhythms in patients recovering from cardiac surgery. Participants wear the patch for up to a week after leaving the intensive care unit. The goal is to see if the device can reliably transmit real-time ECG data and detect arrhythmias, potentially offering a simpler alternative to traditional wired monitors.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a wearable adhesive ECG monitoring device called MEMO Patch Plus
What this could lead to
If successful, this AI-powered patch could offer a more comfortable and reliable way to monitor heart rhythms in hospital patients after surgery.
What could go wrong
This is a very small, early-stage study with only 18 participants. The patch may not detect all arrhythmias or may have transmission issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

18 people

The number who actually took part.

Started

Sep 2022

Finished

Nov 2023

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients undergoing cardiac surgery for cardiac diseases, including aortic valve stenosis, pulmonary valve regurgitation, mitral valve stenosis, mitral valve regurgitation, acute myocardial infarction, unstable angina, stable angina, aortic aneurysm, aortic dissection, atrial septal defect, cardiac tumor, and atrial fibrillation * Patients who voluntarily decide to participate in this clinical study and provide written informed consent Exclusion Criteria: * Patients younger than 19 years of age or 80 years of age or older * Pregnant or lactating women * Patients whom the investigator judges to be unsuitable for participation in this clinical study or whose participation may increase the risk to the patient * Patients with sensitive skin, an allergic reaction to silicone, or skin rash at the intended device application site * Patients who, due to cognitive vulnerability, are judged to be unable to understand the information related to the study, appreciate its significance, and make an independent voluntary decision regarding participation Hemodynamically unstable patients, including those receiving extracorporeal membrane oxygenation (ECMO) or high-dose inotropic support (e.g., epinephrine) * Patients whom the investigator considers inappropriate for participation in this clinical study for ethical reasons or because participation may affect the study results. Specific reasons will be documented in the source records.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute myocardial infarction are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myocardial infarction aortic aneurysm aortic valve stenosis Arrhythmias, Cardiac atrial fibrillation atrial septal defect cardiac rhythm disease heart cancer heart disorder intermediate coronary syndrome mitral valve insufficiency mitral valve stenosis pulmonary valve insufficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiac arrhythmias Cardiac surgery Heart diseases

Contacts and locations

Locations

  • Korea University Anam Hospital

    Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.